Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine
Robert D. Gibbons*, Kwan Hur, C. Hendricks Brown, John M. Davis, J. John Mann
Dive into the research topics of 'Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine'. Together they form a unique fingerprint.